‘Adriaan supports us with strategic insight and an invaluable network of people in the sector’, according to Dr Martin Groher. Currently Adriaan leads the Series A, which will help kickstart the company in major collaborations with R&D departments in biotech and pharma'
‘Adriaan believed in the prospects of our company, also in periods with setbacks’
"Adriaan helped us tremendously to focus all efforts on CE approval. In that stage we needed to conduct clinical studies that not only answered the demands of regulators, but that would also demonstrate the benefits to users and patients"
"The advice that Adriaan gave us on our clinical development program was very important. It is always a great benefit to have people on the board with specific knowledge"